Pre-market Hot Trades in US Stocks
Lianhe Sowell is up 10.19% in pre-market trading. Based on recent key news:
<ol>
<li>
On January 28, Lianhe Sowell International announced that it received a notification from Nasdaq stating that it failed to meet the minimum bid requirement. According to Nasdaq listing rules, the company has 180 days to regain compliance. This news drove the stock price up by 13.70%. Source: PR Newswire
</li>
<li>
On January 26, Lianhe Sowell International issued a statement via PR Newswire emphasizing the company's responsibility for information. This announcement did not have a significant impact on the stock price. Source: PR Newswire
</li>
<li>
On January 28, the company released original content through the EDGAR system, further emphasizing information transparency. This move did not have a significant impact on the stock price. Source: EDGAR The market remains focused on compliance issues.
</li>
</ol>
International Paper is up 7.21% in pre-market trading. Based on recent key news:
<ol>
<li>
On January 29, International Paper is reportedly considering a spin-off. This news has sparked market interest in the company's future strategy, driving the stock price up.
</li>
<li>
On January 26, the packaging company American Packaging Corporation announced it would raise containerboard prices to $70 per ton. The market expects International Paper may follow this price adjustment, further stimulating the stock price increase.
</li>
<li>
On January 26, Jefferies' market survey indicated that demand in the containerboard market is stable but seasonally enhanced, with increased demand during the agricultural season and the impact of 9.4% of capacity closures beginning to show, supporting price increases. Seasonal demand in the containerboard industry is enhancing, leading to price increases.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Serina Therapeutics is up 74.63% in pre-market trading. Based on recent key news:
<ol>
<li>
On January 28, Serina Therapeutics announced that its drug SER-252 for the treatment of advanced Parkinson's disease received IND application approval from the FDA. This news significantly boosted the stock price, reflecting a positive market response to the drug's potential. Source: Reuters
</li>
<li>
On January 28, the company published relevant information on the EDGAR system, further confirming the FDA approval news and enhancing investor confidence. Source: EDGAR
</li>
<li>
On January 29, Benzinga's stock ranking indicated that Serina Therapeutics had a negative price trend across all time frames, but the FDA approval news clearly changed market sentiment. Source: Benzinga Recent policy support in the biotechnology industry has led to significant capital inflows.
</li>
</ol>
Expion360 is up 34.21% in pre-market trading. Based on recent key news:
<ol>
<li>
On January 28, Expion360 released its preliminary annual financial results for the year ending December 31, 2025, expecting revenue of approximately $9.6 million, gross profit of approximately $2.2 million, and a net loss of approximately $6.2 million. These preliminary figures may change after year-end accounting procedures and audits are completed. This news was released by Expion360 through GlobeNewswire, reflecting changes in the company's financial condition, leading to stock price fluctuations.
</li>
<li>
On January 29, Benzinga's stock ranking showed that XPON's price trend was negative across all time frames, reflecting a significant decline in investor confidence, suggesting that the stock is struggling to find a stable footing. This negative trend further exacerbated market concerns about the stock, affecting its price.
</li>
<li>
No other significant news recently. The market reacted strongly to the financial report results, with significant volatility.
</li>
</ol>
Venu pre-market rose 29.77%. Based on recent key news:
<ol>
<li>
On January 29, Venu announced the cancellation of its planned $75 million stock issuance due to unfavorable market conditions for shareholders. This move led to a 25.9% increase in the stock price in pre-market trading. Source: Reuters
</li>
<li>
On January 28, Venu's stock fell sharply by 40% after announcing the issuance plan, hitting a historical low of $5.14. Subsequently, the news of the cancellation of the issuance boosted market confidence. Source: MT Newswires
</li>
<li>
On January 27, Venu planned to raise funds through stock issuance for the development of multiple projects, but the market reacted negatively, causing the stock price to drop over 18% in after-hours trading. Source: MT Newswires The entertainment industry is expanding, and market volatility is significant
</li>
</ol>

LHSW

Lianhe Sowell pre-market up 10.19%; International Paper pre-market up 7.21%; Serina Therapeutics pre-market up 74.63%; Expion360 pre-market up 34.21%; Venu pre-market up 29.77%

Pre-market hot trades in US stocks: Lianhe Sowell up 10.19% in pre-market; International Paper up 7.21% in pre-market